Global Market Access
Navigating Global Healthcare Markets with Syenza’s Expertise

Access Beyond Borders
We're inspired by dynamic and diverse global healthcare markets. As a leading value science company, Syenza supports market access activities with global intelligence and local understanding of pricing, reimbursement, and patients. Our philosophy is to drive efficiences through early engagement with payors and decision-makers to increase the probability of success.
Global Market Access Strategy
Outsourced Global Market Access
Value-based Contracting
Service Outcomes
Clients receive actionable insights
in Market Access Landscape Reports, Comparative Pricing Reports, and Value-Positioning Workshops.
Clients fill capacity gaps in market access organizations with EMAT to enhance launch and post-launch activities.
Clients apply in-market insights to develop value-based contracts that support access to innovations in different markets.
View Our Recent Case Study
Biopharmaceutical Market Access Analysis in Dubai
August 23, 2022
Objective : A market access landscape analysis is the first step to improving access in the target countries. This involved identifying the unmet need in the disease area, audiences with which to build a shared agenda, and shaping national reimbursem
Read More
View Our Recent Articles
Driving Economic Transformation through Brain Health...
🧠 Is Africa ready to invest in its brain health for economic transformation? The Johannesburg Communiqué emphasizes that prioritizing brain health is essential for the continent's growth as it gears up for a w...
Novartis Drug Pricing Agreement
💊 What if lowering drug prices was just the beginning? Novartis has taken a bold step with the US government, reaching an agreement to lower prices for innovative medicines while committing to expand its manufact...
mRNA Vaccine Advancements: Transforming Infectious...
Could mRNA and needle‑free vaccines finally make lifesaving protection truly global? 🌍 Experts say next‑gen mRNA platforms, microneedle patches and mucosal delivery could extend protection beyond COVID‑19 to RSV, en...